Inotiv Inc. 2024 Investor Presentation

Inotiv is a global contract research organization (CRO) offering research science, models and services for drug discovery and development. The company operates two segments: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS), serving over 4,200 clients globally with annual revenue of $572.4 million in FY'23.